Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

Inhibrx, Inc. logo (PRNewsfoto/Inhibrx ... cohort to validate these findings in a more uniform patient population. The cohort is expected to enroll up to 50 patients, each with two to three ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

Generation Beta officially starts this year. Researchers have already predicted the world they will come of age in.

PK data from Cohorts 1 and 2 consistent with preclinical and Phase 0 trial results BOSTON, Feb. 6, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company ...

Cushman & Wakefield’s Head of Life Sciences and Healthcare Insights Sandy Romero recently noted that the most recent medical ...

New Orleans artist Tahj Williams used to stitch the Super Bowl logo and theme art in her sewing room, and now her creation is ...